Zanubrutinib PLUS RCHOP(ZR-CHOP) Regimen Achieves High Complete Response Rate in the Treatment of NewlyDiagnosed Double-Expression Diffuse Large B Cell LymphomaQiang He,Linna Xie,Rongrong Zhao,Ji Ma,Hui Wang,Jie Li,Chuanli Zhao,Y. Lynn Wang,Zengjun LiBlood(2022)引用 1|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要